Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Fenton Mary Kay received 1,541 Cullinan Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Fenton Mary Kay (Chief Financial Officer) received 1,541 Cullinan Therapeutics, Inc. shares as an award at US$8.60 for US$13,253, leaving 127,921 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 1,541 shares
- Price
- US$8.60
- Value
- US$13,253
- Holding after
- 127,921 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Award | 1,541 | US$8.60 | 127,921 | Direct |
Source
Related
- Cullinan Therapeutics, Inc.
- Fenton Mary Kay
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026